Hepatitis B Virus X Protein Regulates Transactivation Activity and Protein Stability of the Cancer-Amplified Transcription Coactivator ASC-2

Hepatology

Volumn 38, Issue 5, 2003, Pages 1258-1266

  Kong, Hee Jeong ^a   Park, Min Jung ^a   Hong, SunHwa ^a   Yu, Hyun Jung ^a   Lee, Young Chul ^b   Choi, Young Hyun ^c   Cheong, JaeHun ^a  

^a Pusan National University   (South Korea)

^b Chonnam National University   (South Korea)

^c Dong Eui University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING SIGNAL COINTEGRATOR 2; GLUTATHIONE TRANSFERASE; HEPATITIS B VIRUS X PROTEIN; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; GENE ACTIVATION; GENE CONTROL; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; INFLAMMATION; LIVER CANCER; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RAT; REGULATORY MECHANISM; TISSUE DISTRIBUTION; TRANSACTIVATION; TRANSCRIPTION INITIATION;

EID: 0142182771     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50451     Document Type: Article

References (37)

1. Ganem D, Varmus HE. The molecular biology of the hepatitis B viruses. Annu Rev Biochem 1987;56:651-695.
2. Murakami S. Hepatitis B virus X protein: structure, function and biology. Intervirology 1999;42:81-99.
3. Cheong J, Yi M, Lin Y, Murakami S. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J 1995;14:143-150.
4. Qadri I, Maguire HF, Siddiqui A. Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc Natl Acad Sci U S A 1995;92:1003-1007.
5. Perini G, Oetjen E, Green MR. The hepatitis B pX protein promotes dimerization and DNA binding of cellular basic region/leucine zipper proteins by targeting the conserved basic region. J Biol Chem 1999;273: 27097-27103.
6. Benn J, Schneider RJ. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci U S A 1994;91:10350-10354.
7. Chirillo P, Falco M, Puri PL, Artini M, Balsano C, Levrero M, Natoli G. Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway. J Virol 1996;70:641-646.
8. Klein NP, Schneider RJ. Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol Cell Biol 1997; 17: 6427-6436.
9. Lee Y, Yun Y. HBx protein of hepatitis B virus activates Jak1-STAT signaling. J Biol Chem 1998;273:25510-25515.
10. Lee SK, Anzick SL, Choi JE, Bubendorf L, Guan XY, Jung YK, Kallioniemi OP, et al. A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. J Biol Chem 1999;274:34283-34293.
11. Zhu Y, Kan L, Qi C, Kanwar YS, Yeldandi AV, Rao MS, Reddy JK. Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR. J Biol Chem 2000;275:13510-13516.
12. Mahajan MA, Samuels HH. A new family of nuclear receptor coregulators that integrate nuclear receptor signaling through CREB-binding protein. Mol Cell Biol 2000;20:5048-5063.
13. Ko L, Cardona GR, Chin WW. Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator. Proc Natl Acad Sci U S A 2000;97:6212-6217.
14. Caira F, Antonson P, Pelto-Huikko M, Treuter E, Gustafsson JA. Cloning and characterization of RAP250, a novel nuclear receptor coactivator. J Biol Chem 2000;275:5308-5317.
15. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997;277:965-968.
16. Lee SK, Na SY, Jung SY, Choi JE, Jhun BH, Cheong J, Meltzet PS, et al. Activating protein-1, nuclear factor-kappaB, and serum response factor as novel target molecules of the cancer-amplified transcription coactivator ASC-2. Mol Endocrinol 2000;4:915-925.
17. Kong HJ, Hong S, Lee MY, Kim HD, Lee JW, Cheong J. Direct binding of hepatitis B virus X protein and retinold X receptor contributes to phosphoenolpyruvate carboxykinase gene transactivation. FEBS Lett 2000;483:114-118.
18. Murakami S, Cheong J, Kaneko S. Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein. J Biol Chem 1994;269:15118-15123.
19. Shuman JD, Cheong J, Coligan JE. ATF-2 and C/EBPalpha can form a heterodimeric DNA binding complex in vitro. Functional implications for transcriptional regulation. J Biol Chem 1997;272:12793-12800.
20. Cheong J, Coligan JE, Shuman JD. Activating transcription factor-2 regulates phosphoenolpyruvate carboxykinase transcription through a stress-inducible mitogen-activated protein kinase pathway. J Biol Chem 1998; 273:22714-11718.
21. Jones KA, Kadonaga JT. Exploring the transcription-chromatin interface. Genes Dev 2000;14:1992-1996.
22. Kadonaga JT. Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines. Cell 1998;92:307-313.
23. Kornberg RD, Lorch Y. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 1999;98:285-294.
24. Lemon BD, Freedman LP. Nuclear receptor cofactors as chromatin remodelers. Curr Opin Genet Dev 1999;9:499-504.
25. Carey M. The enhanceosome and transcriptional synergy. Cell 1998;92: 5-8.
26. Lemon B, Tjian R. Orchestrated response: a symphony of transcription factors for gene control. Genes Dev 2000;14:2551-2569.
27. Holstege FC, Young RA. Transcriptional regulation: contending with complexity. Proc Natl Acad Sci U S A 1999;96:2-4.
28. Xu L, Glass CK, Rosenfeld MG. Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev 1999;9:140-147.
29. Koike K, Moriya K, Yotsuyanagi H, Lino S, Kurokawa K. Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J Clin Invest 1994;94:44-49.
30. Benn J, Schneider RJ. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci U S A 1995;92:11215-11219.
31. Sun BS, Zhu X, Clayton MM, Pan J, Feitelson MA. Identification of a protein isolated from senescent human cells that binds to hepatitis B virus X antigen. HEPATOLOGY 1998;27:228-239.
32. Arii M, Takada S, Koike K. Identification of three essential regions of hepatitis B virus X protein for trans-activation function. Oncogene 1992; 7:397-403.
33. Hu Z, Zhang Z, Doo E, Coux O, Goldberg AL, Liang TJ. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol 1999;73:7231-7240
34. Coux O, Tanaka K, Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996;65:801-847.
35. Rousset R, Desbois C, Bantignies F, Jalinot P. Effects on NF-kappa B1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome. Nature 1996;381:328-331.
36. Seeger M, Ferrell K, Frank R, Dubiel W. HIV-1 tat inhibits the 20 S proteasome and its 11 S regulator-mediated activation. J Biol Chem 1997; 272:8145-8148.
37. Zimmermann J, Erdmann D, Lalande I, Grossenbacher R, Noorani M, Furst P. Proteasome inhibitor induced gene expression profiles reveal overexpression of transcriptional regulators ATF3, GADD153 and MAD1. Oncogene 2000;19:2913-2920.